Header Logo

Connection

Jennifer Vega to Nicotine

This is a "connection" page, showing publications Jennifer Vega has written about Nicotine.
Connection Strength

0.975
  1. Vega JN, Albert KM, Mayer IA, Taylor WD, Newhouse PA. Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study. J Cancer Surviv. 2019 Oct; 13(5):673-686.
    View in: PubMed
    Score: 0.596
  2. Andrews P, Vega JN, Szymkowicz SM, Newhouse P, Tyndale R, Elson D, Kang H, Siddiqi S, Tyner EB, Mather K, Gunning FM, Taylor WD. Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression. J Affect Disord. 2024 Oct 01; 362:416-424.
    View in: PubMed
    Score: 0.210
  3. Vega JN, Albert KM, Mayer IA, Taylor WD, Newhouse PA. Subjective cognition and mood in persistent chemotherapy-related cognitive impairment. J Cancer Surviv. 2022 06; 16(3):614-623.
    View in: PubMed
    Score: 0.169
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.